Signaling pathways, including the MAPK, PI3K, focal adhesion‐PI3K/AKT/mTOR, and EGFR pathways, were enriched in gliomas with high MAPK4 expression (Figure 8A). This evidence concerns the gene AKT1 and central nervous system cancer.